MedPath

Survey and comparative study to Evaluate the efficacy of Ayurvedic formulation and Shirodhara in Attention Deficit Hyperactivity Disorder.

Phase 2
Conditions
Health Condition 1: null- ADHD(Attention Deficit Hyperactivity Disorder)
Registration Number
CTRI/2018/05/014001
Lead Sponsor
Dr Rakesh Kumar Nagar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)School children aged between 6 to 12 years.

2)Having sign and symptoms for ADHD.

3)Children with average/normal IQ

Exclusion Criteria

1)Children with known physical disability (

deafness or visual problems)

2)Children with psychiatric disorders.

3)Children with gross brain damage causing

mental retardation.

4)Children with any genetic disorder

5) Children with

•Epilepsy

•on chronic medication(e.g. steroids)

•previous history of an infectious disease

involving central nervous system (e.g.

encephalitis)

•intellectual disability

•autism

6) Unreliable history.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1)To study the prevalence of ADHD in school children (6-12 years) in Jaipur, Rajasthan. <br/ ><br>2)To study the gender difference in prevalence of ADHD. <br/ ><br>3)To assess the efficacy of tab. Eleva and Shirodhara in Attention Deficit Hyperactivity Disorder. <br/ ><br>Timepoint: 3 months <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
To provide relief in the symptoms of ADHDTimepoint: 3 Months
© Copyright 2025. All Rights Reserved by MedPath